CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
CTOR Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 8-K - Current report
Key Events
2026-03-31 · Key Events
Form 8-K - Current report
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-03-04
Form 8-K - Current report
Key Events
2026-03-04 · Key Events
Form 8-K - Current report
2026-03-03
Form EFFECT - Notice of Effectiveness
2026-03-03 ·
Form EFFECT - Notice of Effectiveness
2026-02-20
Form POS AM - Post-Effective amendments for registration statement
2026-02-20 ·
Form POS AM - Post-Effective amendments for registration statement
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13
Form 8-K - Current report
Key Events
2026-02-13 · Key Events
Form 8-K - Current report
2026-02-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-01-29
Form DEF 14C - Other definitive information statements
2026-01-29 ·
Form DEF 14C - Other definitive information statements
2026-01-20
Form PRE 14C - Other preliminary information statements
2026-01-20 ·
Form PRE 14C - Other preliminary information statements
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
